AG
KROS icon

Algert Global’s Keros Therapeutics KROS Stock Holding History

Algert Global’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-193,607
Closed -$3.94M – 1257
2025
Q4 		$3.94M Buy
193,607
+145,828
+305% +$2.56M 0.06% 520
2025
Q3 		$756K Sell
47,779
-7,791
-14% -$115K 0.01% 875
2025
Q2 		$742K Buy
55,570
+28,090
+102% +$379K 0.02% 863
2025
Q1 		$280K Buy
27,480
+14,783
+116% +$172K 0.01% 1025
2024
Q4 		$201K Buy
12,697
+2,617
+26% +$136K ﹤0.01% 1076
2024
Q3 		$585K Sell
10,080
-5,620
-36% -$278K 0.02% 870
2024
Q2 		$717K Buy
15,700
+1,505
+11% +$80.9K 0.02% 776
2024
Q1 		$940K Buy
14,195
+3,560
+33% +$211K 0.04% 627
2023
Q4 		$423K Hold
10,635
– – 0.02% 865
2023
Q3 		$339K Sell
10,635
-5,960
-36% -$223K 0.02% 857
2023
Q2 		$667K Hold
16,595
– – 0.03% 752
2023
Q1 		$709K Buy
+16,595
New +$838K 0.03% 744

Other funds holding KROS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return